For the first time, British scientists have managed to correct a gene mutation in a patient's stem cells which could lead to specific therapies, such as liver transplant, to be brought into the public domain.

Our science correspondent Tom Feilden explains the findings and Cambridge University's Professor David Lomas talks about its implications.

Get in touch with Today via email , Twitter or Facebook or text us on 84844.